NEW YORK (AP) - Pfizer said Friday that its drug Torisel failed to help patients with a form of advanced kidney cancer when combined with Roche's drug Avastin.
The study compared renal cell carcinoma patients taking the Torisel-Avastin combination to those taking Avastin plus another cancer drug.
Patients taking the Pfizer combination did not show slower disease progression than those in the other group. Pfizer said.
Torisel is already approved as a stand-alone treatment for advanced renal cell carcinoma.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Winter is invading Texas with a vengeance as snow, sleet and ice were unleashed on much of northern and western sections of the state.
Caldwell County residents gathered Thursday evening to organize their fight against a proposed landfill that they say poses a hazard that they don't need.
The pastor of the Austin church attended by the teacher who was killed Thursday in Benghazi remembered him as a spiritual friend dedicated to improving the lives of others.
In just a few months, Pflugerville will be home to a new water park. It's just the latest development as the community becomes a major suburb.
Global civil rights icon Nelson Mandela, whose legacy is ending South African apartheid, has died.
A man convicted 21 years ago for engaging in ritual child abuse was released Thursday after the DA's office agreed the only physical evidence against him was faulty.